Anti-Human IFNG Recombinant Antibody (Fontolizumab) (CAT#: TAB-041)

Recombinant monoclonal antibody to IFNG. Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease.


Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Published Data
  • Tested Data
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Activ

Figure 1 Mean (SEM) Crohn’s disease activity index (CDAI) for patients receiving two doses of study drug.

Figure 1 Mean (SEM) Crohn’s disease activity index (CDAI) for patients receiving two doses of study drug.

Comparison is change from baseline value for each fontolizumab group versus placebo group.

Hommes, D. W., Mikhajlova, T. L., Stoinov, S., Štimac, D., Vucelic, B., Lonovics, J.,... & Lee, S. (2006). Fontolizumab, a humanised anti-interferon γ antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn’s disease. Gut, 55(8), 1131-1137.


Specifications

  • Immunogen
  • The details of the immunogen for this antibody are not available.
  • Host Species
  • Mouse
  • Derivation
  • Humanized (from mouse)
  • Type
  • IgG1
  • Specificity
  • Tested positive against native human antigen.
  • Species Reactivity
  • Human
  • Applications
  • IP, IF, FuncS, FC, Neut, ELISA, IHC, Activ
  • Trade name
  • huzaf
  • CAS
  • 326859-36-3
  • Generic Name
  • Fontolizumab
  • UNII
  • 6J92H2439Z
  • MW
  • 150 kDa
  • Related Disease
  • Crohn's disease (CD)

Product Property

  • Purity
  • >95.0%, determined by analysis by RP-HPLC & analysis by SDS-PAGE.
  • Storage
  • Store the antibody (in aliquots) at -20°C. Avoid repeated freezing and thawing of samples.

Applications

  • Application Notes
  • The IFNG antibody has been reported in applications of IP, IF, FuncS, FC, Neut, ELISA, IHC, Activ.

Target

  • Alternative Names
  • Fontolizumab;huzaf;326859-36-3;HuZAF;flintozumab;IFNG;interferon, gamma;interferon gamma;IFN-gamma;immune interferon;IFG;IFI;

Related Resources

  • Biosimilar Overview
  • Related Diseases
Please refer to Fontolizumab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Fontolizumab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Fontolizumab"

Afuco™ Anti-IFNG ADCC Recombinant Antibody (Fontolizumab), ADCC Enhanced
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to IFNG. Fontolizumab (planned trade name HuZAF) is a humanized monoclonal antibody and an immunosuppressive drug for the treatment of auto-immune diseases like Crohn's disease.

See other products for "IFNG"

Mouse Antibody

CAT Product Name Application Type
MOB-0289MC Recombinant Anti-Canine IFN-gamma Antibody. WB, ELISA

Humanized Antibody

Neutralizing Antibody

CAT Product Name Application Type
NEUT-1017CQ Mouse Anti-IFNG Recombinant Antibody (clone MD-1) ELISA, ELISPOT, Neut, WB, FC, IHC-Fr Mouse IgG1
NEUT-1018CQ Mouse Anti-IFNG Recombinant Antibody (clone NIB42) ELISA, Neut, IP, RIA Mouse IgG1
NEUT-1019CQ Mouse Anti-Ifng Recombinant Antibody (clone CBL981) ELISA, Neut, WB Mouse IgG1
NEUT-1020CQ Rat Anti-Ifng Recombinant Antibody (clone mAb0854) IHC-Fr, Neut Rat IgG1
NEUT-1021CQ Rat Anti-Ifng Recombinant Antibody (clone R4-6A2) ELISA, IHC, IHC-Fr, Neut, WB Rat IgG1

Epitope-Specific Antibody

CAT Product Name Application Type
EPAF-0882LC Mouse Anti-IFNG Recombinant Antibody (clone MIF3009) ELISA Mouse IgG1

ADCC Enhanced Antibody

CAT Product Name Application Type
AFC-TAB-041 Afuco™ Anti-IFNG ADCC Recombinant Antibody (Fontolizumab), ADCC Enhanced IP, IF, FuncS, FC, Neut, ELISA ADCC enhanced antibody
AFC-TAB-423CQ Afuco™ Anti-IFNG ADCC Recombinant Antibody (Emapalumab), ADCC Enhanced ELISA, IHC, FC, IP, IF, FuncS ADCC enhanced antibody

Customer Reviews and Q&As

Submit a review or a question
There are currently no Customer reviews or questions for TAB-041. Click the button above to contact us or submit your feedback about this product.
View the frequently asked questions answered by Creative Biolabs Support.

For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

© 2024 Creative Biolabs.
  • 0
  • 0
Cart

    Go to compare